FELDAN

Owner

Goods & Services

Pharmaceutical research and development; research and development in the fields of pharmaceuticals, biotechnology, cell therapies, drug delivery technologies, dermatology, oncology, cardiology, gastroenterology, endocrinology, genitourinary, ophthalmology, nephrology, pulmonology, vascular system, and ischemia; providing medical scientific information in the fields of pharmaceuticals, biotechnology, cell therapies, drug delivery technologies, dermatology, oncology, cardiology, gastroenterology, endocrinology, genitourinary, ophthalmology, nephrology, pulmonology, vascular system, and ischemia; drug discovery services.

Pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases, chronic wound, skin cancer, precancerous skin lesions, skin fibrosis and treatment of acne; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases, disorders and infections; pharmaceutical preparations for treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of genetic disorders; pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, namely, cerebrovascular accident (stroke), parkinson's disease, multiple sclerosis, myasthenia gravis, huntington's disease; pharmaceutical preparations for the treatment of neurological disorders, namely, brain injury, spinal cord injury, seizure disorders; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia and obesity; pharmaceutical preparations for the treatment of infectious diseases, namely respiratory infections, eye infections, bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders; pharmaceutical preparations for use in the treatment of musculoskeletal diseases and disorders; pharmaceutical preparations for diagnosing and treating neurodegenerative diseases; cardiovascular pharmaceutical preparations; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders; pharmaceutical preparations for the treatment of endocrine diseases, namely, glucagonoma; dermatological pharmaceutical preparations for the treatment of psoriasis; dermatological pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the diagnosis of oncological diseases and disorders; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations.